Skip to content
stoqly

Ingersoll Rand

IR NYSE Industrial Machinery & Supplies & Components Financials FY2016–FY2025

Ingersoll Rand's revenue rose 5.8% to $7.7 billion in fiscal 2025. Its operating margin was 15.0%, down from 18.0% a year earlier. Free cash flow was $1.2 billion, down 2.2%. It paid out $1.0 billion in dividends and buybacks, 86% of free cash flow. The diluted share count fell 1.5%.

Last close Β· Oct 23, 2026

$73.48

0.9%
Revenue Total sales reported in the income statement.
$7.7B
5.7% vs prior year
Operating margin Operating income as a share of revenue.
15.0%
3.0 pts
Net income Profit after all expenses, interest and tax.
$581M
30.7%
Free cash flow Cash from operations minus capital spending.
$1.2B
2.2%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
6.5%
1.7 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$28.8B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
30.2x
On $2.43 EPS (TTM)

What Ingersoll Rand does

No business description yet.

Legal name
Ingersoll Rand Inc.
Fiscal year ends
December 31, 2025
Latest annual report
β€”
Accession Β· CIK
0001628280-26-008617
0001699150

Revenue and margins

Ingersoll Rand had $7.7B of revenue in fiscal 2025, up 5.8% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $1.2B in fiscal 2025, 16.0% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Ingersoll Rand returned $1.0B to shareholders in fiscal 2025, 86% of free cash flow. The diluted share count fell 1.5%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Ingersoll Rand yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$3.5B and divides by 401.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 30.2x Β· peers 24.6x Β· sector 26.0x.

Balance sheet

Cash, debt and the ratios that show how comfortably Ingersoll Rand can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $2.1B$1.6B$1.6B$1.5B$1.2B
Debt incl. finance leases $2.8B$2.8B$2.7B$4.8B$4.8B
Net debt / EBITDA 0.7x0.9x0.7x1.8x2.1x
Debt / equity 0.3x0.3x0.3x0.5x0.5x
Interest coverage 6.5x7.9x7.4x6.1x4.5x
Current ratio 2.8x2.4x2.2x2.3x2.1x
Quick ratio 2.2x1.8x1.7x1.7x1.5x
Total assets $15.2B$14.8B$15.6B$18.0B$18.3B
Total liabilities $6.1B$5.5B$5.7B$7.8B$8.1B
Shareholders' equity $9.0B$9.2B$9.8B$10.2B$10.1B
Net debt (βˆ’ = net cash) $686M$1.1B$1.1B$3.2B$3.5B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$1.0M

1 insider

Sold, 12 months

$32.8M

7 insiders

Of sales under plans

70%

$23.0M

DateInsiderTradeSharesPriceValueFiling
Aug 3, 2026 Aurobind SatpathyDirector Bought 11,538 $86.68 $1.0M Form 4
Apr 13, 2026 Vicente ReynalSee Remarks, Director Sold plan 30,492 $88.00 $2.7M Form 4
Mar 2, 2026 Vicente ReynalSee Remarks, Director Sold plan 118,044 $94.11 $11.1M Form 4
Feb 20, 2026 Vikram KiniSenior Vice President and CFO Sold 28,367 $96.50 $2.7M Form 4
Feb 19, 2026 John HumphreyDirector Sold 4,300 $95.90 $0.4M Form 4
Feb 18, 2026 Vicente ReynalSee Remarks, Director Sold plan 900 $100.00 $0.1M Form 4
Feb 17, 2026 Andrew R SchieslSee Remarks Sold 18,000 $98.00 $1.8M Form 4
Feb 17, 2026 Elizabeth Meloy HepdingSee Remarks Sold 18,246 $97.11 $1.8M Form 4
Feb 17, 2026 Kathleen M. KeeneSee Remarks Sold 12,000 $99.46 $1.2M Form 4
Feb 17, 2026 Michael J ScheskeVP, Chief Accounting Officer Sold 19,122 $97.67 $1.9M Form 4
Feb 17, 2026 Vicente ReynalSee Remarks, Director Sold plan 36,482 $97.50 $3.6M Form 4
Feb 13, 2026 Vicente ReynalSee Remarks, Director Sold plan 55,870 $100.39 $5.6M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ“ βœ“ βœ•
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ“ βœ• βœ“
Current ratio rose βœ• βœ“ βœ•
Share count didn't rise βœ“ βœ“ βœ“
Gross margin rose βœ“ βœ“ βœ•
Revenue rose relative to assets βœ“ βœ• βœ•
F-score 8 / 97 / 95 / 9
Accruals ratio βˆ’4.0%βˆ’3.3%βˆ’4.3%
Altman Z'' 3.603.183.06

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Ingersoll Rand IR $28.8B 5.8% 15.0% 16.0% 6.5% 30.2x 5
Dover DOV $26.9B 4.5% 17.0% 13.8% 12.0% 23.2x 5 Compare β†’
Xylem XYL $25.7B 5.5% 13.5% 10.1% 8.1% 25.9x 6 Compare β†’
Hubbell HUBB $23.9B 3.8% 20.7% 15.0% 18.7% 26.5x 7 Compare β†’
Snap-on SNA $18.7B 0.9% 25.8% 19.5% 19.2% 18.6x 6 Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $1.9B $2.4B $2.7B $2.0B $4.0B $5.2B $5.9B $6.9B $7.2B $7.7B
Gross profit $717M $898M $1.0B $778M $1.4B $2.0B $2.3B $2.9B $3.2B $3.3B
Research and development $22.0M $26.0M $24.0M $22.0M $58.0M $74.0M $91.3M $108M $117M $114M
Operating income $104M $109M $443M $194M $59.6M $566M $817M $1.2B $1.3B $1.1B
Interest expense $170M $141M $99.6M $88.4M $111M $87.7M $103M $157M $213M $254M
Pretax income βˆ’$63.2M βˆ’$113M $350M $110M βˆ’$45.4M $513M $742M $1.0B $1.1B $935M
Income tax βˆ’$31.9M βˆ’$131M $80.1M $12.9M $11.4M βˆ’$21.8M $150M $240M $263M $219M
Net income βˆ’$36.6M $18.4M $269M $159M βˆ’$33.3M $563M $605M $779M $839M $581M
Diluted EPS βˆ’$0.25 $0.10 $1.29 $0.76 βˆ’$0.09 $1.34 $1.47 $1.90 $2.06 $1.45
Diluted shares 0.15B 0.19B 0.21B 0.21B 0.38B 0.42B 0.41B 0.41B 0.41B 0.40B
Cash flow
Cash from operations $166M $201M $445M $343M $914M $628M $865M $1.4B $1.4B $1.4B
Capital expenditure $74.4M $56.8M $52.2M $37.9M $42.0M $64.1M $94.6M $105M $149M $136M
Free cash flow $91.2M $144M $392M $305M $872M $564M $771M $1.3B $1.2B $1.2B
Depreciation and amortization $173M $174M $180M $147M $413M $422M $433M $459M $482M $506M
Stock-based compensation $0.0M $175M $2.8M $18.7M $47.5M $87.2M $78.9M $51.9M $58.8M $53.0M
Acquisitions $18.8M $18.8M $186M $12.0M $9.0M $975M $247M $963M $3.0B $525M
Share buybacks $14.1M $3.6M $40.7M $18.6M $2.1M $737M $261M $263M $261M $1.0B
Dividends paid $0.0M $0.0M $0.0M $0.0M $0.0M $8.2M $32.4M $32.4M $32.3M $31.8M
Dividends and buybacks $14.1M $3.6M $40.7M $18.6M $2.1M $745M $294M $295M $293M $1.0B
Balance sheet
Cash and short-term investments $256M $393M $221M $506M $1.8B $2.1B $1.6B $1.6B $1.5B $1.2B
Total debt $2.8B $2.0B $1.7B $1.6B $3.9B $2.8B $2.8B $2.7B $4.8B $4.8B
Finance lease liabilities $0.0M $0.0M $0.0M $17.9M $17.2M $17.1M $16.1M $14.9M $13.9M $12.5M
Current assets $1.2B $1.5B $1.3B $1.5B $3.9B $4.1B $4.0B $4.1B $4.2B $4.2B
Current liabilities $498M $562M $596M $575M $1.5B $1.5B $1.7B $1.8B $1.8B $2.1B
Inventory $444M $495M $524M $503M $717M $854M $1.0B $1.0B $1.1B $1.2B
Property and equipment, net $358M $363M $357M $327M $609M $649M $624M $711M $842M $930M
Total assets $4.3B $4.6B $4.5B $4.6B $16.1B $15.2B $14.8B $15.6B $18.0B $18.3B
Total liabilities $4.0B $3.1B $2.8B $2.8B $6.9B $6.1B $5.5B $5.7B $7.8B $8.1B
Shareholders' equity $266M $1.5B $1.7B $1.9B $9.1B $9.0B $9.2B $9.8B $10.2B $10.1B
Margins
Gross margin 37.0% 37.8% 37.6% 38.6% 35.4% 38.6% 39.3% 41.9% 43.8% 43.6%
Operating margin 5.3% 4.6% 16.5% 9.6% 1.5% 11.0% 13.8% 16.9% 18.0% 15.0%
EBITDA margin 14.2% 11.9% 23.2% 16.9% 11.9% 19.2% 21.1% 23.6% 24.6% 21.6%
Net margin βˆ’1.9% 0.8% 10.0% 7.9% βˆ’0.8% 10.9% 10.2% 11.3% 11.6% 7.6%
FCF margin 4.7% 6.1% 14.6% 15.1% 22.0% 10.9% 13.0% 18.5% 17.2% 16.0%
Returns
Return on capital β€” 2.9% 10.9% 5.6% 0.7% 5.4% 6.5% 8.4% 8.2% 6.5%
Return on capital employed β€” 2.8% 11.1% 4.9% 0.6% 4.0% 6.1% 8.7% 8.7% 7.1%
Return on equity βˆ’10.9% 2.1% 17.1% 9.0% βˆ’0.6% 6.2% 6.7% 8.2% 8.4% 5.7%
Return on assets βˆ’0.8% 0.4% 5.9% 3.5% βˆ’0.3% 3.6% 4.0% 5.1% 5.0% 3.2%
Growth
Revenue growth βˆ’8.8% 22.5% 13.2% βˆ’25.0% 96.9% 29.7% 14.8% 16.2% 5.2% 5.8%
Net income growth β€” β€” 1,364.1% βˆ’40.9% βˆ’120.9% β€” 7.5% 28.8% 7.7% βˆ’30.7%
EPS growth β€” β€” 1,190.0% βˆ’41.1% βˆ’111.8% β€” 9.7% 29.3% 8.4% βˆ’29.6%
FCF growth βˆ’9.8% 57.6% 173.0% βˆ’22.2% 185.6% βˆ’35.4% 36.7% 65.0% βˆ’1.9% βˆ’2.2%
Share count change βˆ’0.3% 26.3% 11.0% βˆ’0.1% 83.3% 10.0% βˆ’2.6% βˆ’0.3% βˆ’0.4% βˆ’1.5%
Financial health
Net debt / EBITDA 9.1x 5.8x 2.3x 3.3x 4.6x 0.7x 0.9x 0.7x 1.8x 2.1x
Debt / equity 10.5x 1.4x 1.0x 0.9x 0.4x 0.3x 0.3x 0.3x 0.5x 0.5x
Interest coverage 0.6x 0.8x 4.5x 2.2x 0.5x 6.5x 7.9x 7.4x 6.1x 4.5x
Current ratio 2.4x 2.6x 2.2x 2.7x 2.6x 2.8x 2.4x 2.2x 2.3x 2.1x
Quick ratio 1.5x 1.7x 1.4x 1.8x 2.1x 2.2x 1.8x 1.7x 1.7x 1.5x
Capital allocation
Capex / revenue 3.8% 2.4% 1.9% 1.9% 1.1% 1.2% 1.6% 1.5% 2.1% 1.8%
Stock comp / revenue 0.0% 7.4% 0.1% 0.9% 1.2% 1.7% 1.3% 0.8% 0.8% 0.7%
Payouts / FCF 15.5% 2.5% 10.4% 6.1% 0.2% 132.2% 38.1% 23.2% 23.5% 86.0%
Quality scores
Piotroski F-score β€” 8.0 6.0 7.0 3.0 7.0 7.0 8.0 7.0 5.0
Altman Z'' 0.8 1.5 2.1 2.3 2.4 3.0 3.4 3.6 3.2 3.1
Accruals ratio βˆ’4.6% βˆ’4.1% βˆ’3.8% βˆ’4.0% βˆ’9.2% βˆ’0.4% βˆ’1.7% βˆ’4.0% βˆ’3.3% βˆ’4.3%

Source: SEC EDGAR XBRL filings (CIK 0001699150). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open